Read + Share
. Retraction: Improvement of non-invasive tests of liver steatosis and fibrosis as
indicators for non-alcoholic fatty liver disease in type 2 diabetes mellitus
patients with elevated cardiovascular risk profile using the PPAR-alpha/gamma agonist
aleglit PLoS One 2025;20:e0339230.
PMID: 41417715
|
 |
|
